-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Galera Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
- Galera Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$5.58M, a 63% increase year-over-year.
- Galera Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$19.6M, a 71.9% increase year-over-year.
- Galera Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$59.1M, a 5.05% increase from 2022.
- Galera Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$62.2M, a 22.7% increase from 2021.
- Galera Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$80.5M, a 8.51% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)